Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Arch Pharmalabs Limited, is an unlisted public company incorporated on 02 April, 1993. It is classified as a public limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 3,000.00 cr and the total paid-up capital is INR 156.48 cr.
Arch Pharmalabs Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2022. It's book networth has increased by 185.26%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2022 numbers.
85.4%
-96.85%
185.26%
-25.83%
-1.6%
-9.23
111.15
-235.76
-894.29
73.88
-3.94
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(11)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Axis Trustee Services Limited
No. of Loans: 4
Total Amount : 2,187.6 cr
JM Financial Asset Reconstruction Company Private Limited
No. of Loans: 23
Total Amount : 2,156.8 cr
JM FINANCIAL ASSET RECONSTRUCTION COMPANY LIMITED
No. of Loans: 16
Total Amount : 1,069.3 cr
VISTRA ITCL (INDIA) LIMITED
No. of Loans: 2
Total Amount : 150.0 cr
Canara Bank
No. of Loans: 2
Total Amount : 50.0 cr
State Bank of Indore
No. of Loans: 1
Total Amount : 34.5 cr
Standard Chartered Bank
No. of Loans: 1
Total Amount : 10.0 cr
Centurion Bank of Punjab
No. of Loans: 1
Total Amount : 10.0 cr
RBL Bank Limited
No. of Loans: 1
Total Amount : 0.1 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Whole-time Director | Ashish Mohan Ujagare | 00012613 | 7 years |
| Managing Director | Ajit Annu Kamath | 00032799 | 21 years |
| Whole-time Director | Rajendrakumar Padmanabhan Kaimal | 00032839 | 21 years |
| CFO | Rajendrakumar Padmanabhan Kaimal | <HIDDEN> | 6 years |
| CS | Vikas Bijay Kedia
Shareholder
|
<HIDDEN> | 7 years |
| Director | Sunil Mansukhlal Pitroda | 07028212 | 8 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| VITALIFE PHARMA LIMITED |
Active
|
5.0 L | 3 | Maharashtra |
| ARCH HERBALS PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| ARCH IMPEX PRIVATE LIMITED |
Active
|
2.5 Cr | 2 | Maharashtra |
| ARCH PHYTOCHEMICALS PRIVATE LIMITED |
Amalgamated
|
1.0 L | 1 | Maharashtra |
| ARCH PHARMACHEM LTD |
Active
|
1.2 Cr | 2 | Maharashtra |
| AMRA REMEDIES LIMITED |
Under Liquidation
|
6.1 Cr | 2 | Maharashtra |
| ARCH AGRO INDUSTRIES PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| AMRA RENAL CARE LIMITED |
Active
|
5.1 L | 2 | Maharashtra |
| ARCH LIFE SCIENCES LIMITED |
Active
|
3.9 Cr | 2 | Telangana |
| ARCHPLUS SALES PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| ARCH FINECHEMICALS LIMITED |
Active
|
8.4 Cr | 2 | Telangana |
| KOBO BIOTECH LIMITED |
Active
|
23.8 Cr | 3 | Telangana |
| ACCENTURE HOSPITALITY PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| A M R INVESTMENTS PRIVATE LIMITED |
Under Liquidation
|
3.6 Cr | 2 | Maharashtra |
| ARCH INFRA VENTURES LIMITED |
Strike Off
|
1.5 Cr | 2 | Maharashtra |
| AVANT CAPITAL SERVICES PRIVATE LIMITED |
Amalgamated
|
1.3 L | 1 | Maharashtra |
| ARCH INVESTMENT PRIVATE LIMITED |
Strike Off
|
10.0 L | 2 | Maharashtra |
| SAMRUDH BHARAT SOCIAL WELFARE FOUNDATION |
Active
|
1.0 L | 2 | Maharashtra |
| TACK COMMOSALES LLP |
Active
|
5.0 L | 1 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| ARCH LIFE SCIENCES LIMITED | Telangana | 2003 | ₹ 3.9 Cr |
| ARCH FINECHEMICALS LIMITED | Telangana | 1993 | ₹ 8.4 Cr |
| Arch Pharmalabs FZ LLC | United Arab Emirates | - | - |
| VITALIFE PHARMA LIMITED | Maharashtra | 2021 | ₹ 5.0 L |
The incorporation date of ARCH PHARMALABS LIMITED is 02 April, 1993
The authorized share capital of ARCH PHARMALABS LIMITED is INR ₹ 3,000.0 Cr.
The paid-up capital of ARCH PHARMALABS LIMITED is INR ₹ 156.5 Cr.
The registered address of ARCH PHARMALABS LIMITED is Unit 101/104, Hyde Park, Saki Vihar Road Opp. Ansa Industria l Estate, Andheri (E) Mumbai Mumbai Mumbai Maharashtra - 400072
The CIN number of ARCH PHARMALABS LIMITED is U24231MH1993PLC150891.
Expand
Delete
Collapse
See
details
